Your session is about to expire
← Back to Search
Remote Dietitian + Mobile App for Obesity
N/A
Waitlist Available
Led By Antonia F Chen, MD, MBA
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this outcome will be evaluated at 3 months (10-14 weeks) after study enrollment.
Awards & highlights
Study Summary
This trial is testing a weight loss intervention and mobile app to see if it helps people with morbid obesity lose weight and become eligible for surgery.
Who is the study for?
This trial is for adults over 18 with severe obesity (BMI > 40 kg/m2) considering hip or knee joint replacement surgery at specific hospitals. Participants must own a smartphone or have internet and webcam access, be willing to follow the study's rules, and provide informed consent. People with BMIs over 47 kg/m2, needing revision surgeries, non-English speakers, those planning bariatric surgery or pregnancy within six months are excluded.Check my eligibility
What is being tested?
The trial tests a weight loss program supervised by dietitians through video calls and a mobile app for obese patients before joint replacement surgery. It aims to achieve more significant weight loss than usual care, reduce BMI below the cutoff of 40 kg/m2 making them eligible for surgery, and increase the number undergoing surgery within six months.See study design
What are the potential side effects?
Since this intervention involves dietary changes and physical activity monitored remotely rather than medication or invasive procedures, side effects may include typical reactions to dieting such as fatigue, hunger pangs or digestive changes but should generally be minimal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ this outcome will be evaluated at 3 months (10-14 weeks) after study enrollment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this outcome will be evaluated at 3 months (10-14 weeks) after study enrollment.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of weight lost or gained from baseline
Secondary outcome measures
Change from baseline in HbA1c
Change from baseline in Paving Wheel Wellness score
Change from baseline in serum albumin
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Intervention subjects will use the Nutrimedy mobile app and be connected at enrollment with a registered dietitian who will contact intervention participants weekly or bi-weekly via video calls and unlimited in-app text messaging for up to three months. The first week will include either one 55-minute video session or two 25-minute sessions. Weeks 2-4 will have weekly 25-minute video calls, and weeks 5-12 will have biweekly 25-minute sessions for a total of 8-9 sessions over 12 weeks. Together, participants and dietitians will come up with goals for the 12 weeks, and dietitians will check on progress toward these goals using in-app tools such as food logs and messaging between video calls. All patients will be encouraged to lose at least 20 pounds with a goal BMI<40 kg/m2 after 12 weeks. The intervention group will also receive all aspects of the usual care arm including the opportunity to have a physical therapist and/or nutritionist referral.
Group II: Usual CareActive Control1 Intervention
Individuals randomized to the usual care group will receive standard care. This may include a physical therapist and/or nutritionist referral. Brigham and Women's Hospital offers several programs for patients interested in losing weight, including the Nutrition Wellness Service (NWS) and Program for Weight Management (PWM). Insurance coverage for these programs varies by patient insurance.
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,618 Previous Clinical Trials
11,471,650 Total Patients Enrolled
Vela FoundationUNKNOWN
Antonia F Chen, MD, MBAPrincipal InvestigatorBrigham and Women's Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a joint replacement surgery that needs to be redone.You would be willing to have a complete joint replacement surgery if you meet the requirements.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Oklahoma
Arizona
Texas
Other
How old are they?
65+
18 - 65
What site did they apply to?
Brigham and Women's Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How responsive is this trial?
Typically responds via
Email
Most responsive sites:
- Brigham and Women's Hospital: < 24 hours
Average response time
- < 1 Day
Recent research and studies
Share this study with friends
Copy Link
Messenger